Disruption of Autoregulatory Feedback by a Mutation in a Remote, Ultraconserved PAX6 Enhancer Causes Aniridia  by Bhatia, Shipra et al.
REPORT
Disruption of Autoregulatory Feedback
by a Mutation in a Remote, Ultraconserved
PAX6 Enhancer Causes Aniridia
Shipra Bhatia,1 Hemant Bengani,1 Margaret Fish,2 Alison Brown,1 Maria Teresa Divizia,3
Riccardo de Marco,4 Guiseppe Damante,5 Robert Grainger,2 Veronica van Heyningen,1,*
and Dirk A. Kleinjan1,*
The strictly regulated expression of most pleiotropic developmental control genes is critically dependent on the activity of long-range
cis-regulatory elements. This was revealed by the identification of individuals with a genetic condition lacking coding-region mutations
in the gene commonly associated with the disease but having a variety of nearby chromosomal abnormalities, collectively described as
cis-ruption disease cases. The congenital eyemalformation aniridia is caused by haploinsufficiency of the developmental regulator PAX6.
We discovered a de novo point mutation in an ultraconserved cis-element located 150 kb downstream from PAX6 in an affected indi-
vidual with intact coding region and chromosomal locus. The element SIMO acts as a strong enhancer in developing ocular structures.
The mutation disrupts an autoregulatory PAX6 binding site, causing loss of enhancer activity, resulting in defective maintenance of
PAX6 expression. These findings reveal a distinct regulatory mechanism for genetic disease by disruption of an autoregulatory feedback
loop critical for maintenance of gene expression through development.Advances in genomic sequencing and epigenomics have
firmly established that key developmental regulatory genes
with pleiotropic functions (e.g., PAX6 [MIM 607108], SHH
[MIM 600725], SOX9 [MIM 608160]) are surrounded by
many, often highly conserved cis-regulatory elements,
spread over hundreds of kilobases from the transcription
start site.1,2 Most cis-elements function as transcriptional
enhancers and are the primary determinants of precise
tissue-specific gene regulation. Developments in human
genetics have greatly contributed to recognition of the
fact that the spatiotemporally and quantitatively appro-
priate activity of a gene requires not only the presence of
intact coding sequence but also properly functioning regu-
latory control. However, in contrast to coding-region
mutations, the identification of causal variants in regu-
latory regions and the validation of their role in disruption
of appropriate gene expression remains a major problem.
Nevertheless, because noncoding variation is now recog-
nized as a major factor in both Mendelian and common
genetic disease, the elucidation of the various control
mechanisms whose disruption can have phenotypic con-
sequences is essential for future diagnostic and therapeutic
prospects.
Aniridia (MIM 106210) is a panocular disease character-
ized by a variable degree of iris hypoplasia, foveal hypopla-
sia, nystagmus, and ciliary body abnormalities. Affected
individuals are often afflicted by progressive sight-threat-
ening complications such as glaucoma, cataracts, and
keratopathy resulting from corneal limbal stem cell defi-
ciency.3 Haploinsufficiency of the developmental control
gene PAX6 has been identified as the cause of classical anir-1MRC Human Genetics Unit at the MRC IGMM at the University of Edinburgh
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deletions in around 90% of patients (PAX6 mutation
database) and abnormalities in the genomic region down-
stream of PAX6 in a further set of individuals.4–6 Transcrip-
tional control of Pax6 expression depends on a large array
of cis-elements.7–13 Analysis of people with aniridia car-
rying chromosomal abnormalities 30 of the PAX6 transcrip-
tion unit revealed the crucial role played by a cluster of
distant, highly conserved control elements, the DRR,
encoding a variety of eye and other tissue-specific activities
(Figure 1A).13 Themost distant breakpoints, in two familial
cases with classical aniridia, were identified at 125 kb (SGL)
and 150 kb (SIMO) downstream of the PAX6 P1 promoter
site.4 Nevertheless, an additional group of aniridia-affected
individuals remained for which the causative genetic
defect remains unresolved. The well-established role of
PAX6 coding mutations and chromosomal abnormalities
in aniridia disease etiology presented the opportunity for
exploration of additional mechanisms of cis-regulatory
disruption in this group.
To investigate whether mutations in individual regu-
latory elements could be a further cause of aniridia, we
screened a selection of eye-related cis-regulatory elements
(Table S1) in a panel of 60 subjects without PAX6
exonic mutations or large-scale chromosomal abnormal-
ities, as assessed by exon sequencing, array-CGH (Roche
Nimblegen 12X135k whole-genome array), or MLPA
testing (SALSA MLPA P219-B2 reagent kit, MRC-Holland).
Informed consent was obtained in keeping with the guide-
lines approved by the UK Multiregional Ethics Committee
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Figure 1. Aniridia Subject ID 1230P Carries a Mutation in a Remote, Ultraconserved PAX6 Regulatory Element
(A) Map of the PAX6 locus on human chromosome 11, displaying the exons of PAX6 (black rectangles, top strand) and adjacent ELP4
gene (black rectangles, bottom strand), whose introns contain long-range cis-elements (blue ellipses) for PAX6 (including the distal reg-
ulatory region [DRR]). The SIMO element (orange ellipse), located 150 kb downstream, is deeply conserved with strong sequence sim-
ilarity across vertebrates. The alignment shows the centromeric part of the element. Themutation changes a 100% conserved residue in a
highly conserved sequence block with strong similarity to a PAX6 binding site.
(B) Visualization of evolutionary sequence conservation by percentage identity plot (PIP). Green boxes highlight presence of the element
and purple indicates its absence in the zebrafish pax6.1b locus. Fragments characterized in the EI-Z,13 SIMO-LacZ (SIMO-Z), and SIMO-
GFP transgenic reporters are indicated.
(C) Eye phenotype of the affected individual and his unaffected parents. Slit lamp and close-up photographs of the eyes of subject
ID 1230P show complete absence of an iris (arrowheads) and presence of lens cataracts (arrows) in both eyes. Ocular fundus photography
and horizontal optical coherence tomography (OCT) in comparison with a normal eye reveal absence of a foveal depression in the
subject.
(D) Sequence traces from affected individual and parents show the de novo heterozygous G/T transition in the element. A consensus
PAX6 paired domain binding sequence is shown in alignment above the sequence traces.keeping with the tenets of the Declaration of Helsinki. We
identified one individual with a single de novo nucleotide
variant (chr11: 31,685,945G>T [UCSC Genome BrowserThe American Jouhuman reference sequence hg19]) in an ultraconserved
sequence, SIMO (uc.325),14 located 150 kb downstream
of PAX6 (Figures 1A and 1B, and Figure S1 availablernal of Human Genetics 93, 1126–1134, December 5, 2013 1127
online). Individual ID 1230P (normal karyotype: 46,XY)
was diagnosed with bilateral iris hypoplasia at the age of
two. Aniridia was confirmed at age 17 (Figure 1C) and
detailed ophthalmologic evaluation was performed (Sup-
plemental Data). The G/T variant affects a nucleotide resi-
due conserved more than 350 million years across the
spectrum of bony vertebrates (Figures 1A and 1D). In silico
assessment of the variant base pair and flanking sequences
revealed it as a potential binding site for the PAX6 paired
domain.15,16 Based on the crystal structure of the human
PAX6 paired domain-DNA complex,17 the G to T transver-
sion would be predicted to affect binding by changing a
nucleotide that is critical for paired domain linker-DNA
contact, suggesting that interference with autoregulation
of PAX6 could be the cause of disease in this individual.
To investigate the mechanism that leads from a single
base pair substitution to a debilitating disease, we first per-
formed a detailed characterization of the 800 bp SIMO cis-
element in mouse and zebrafish reporter transgenics. The
experiments were approved by the University of Edin-
burgh ethical committee (TR-20-10) and performed under
UK Home Office license number PPL 60/3785. We
observed LacZ reporter activity in early surface ectoderm,
lens, diencephalon, and rhombencephalon of transgenic
mouse embryos from E9.5 (Figures 2A, 2B, and S2B–S2G)
and in the developing retina from E13.5 onward (Figures
2C, S2H, and S2I). Eye expression continues through later
development and into adulthood (Figures 2C, S2L, and
S2M), where it is seen in the lens epithelium, retina, and
iris. To assess functional conservation of the element, we
made zebrafish GFP reporter transgenics with the mouse
and zebrafish elements. Both elements produced similar
patterns, being inactive at 24 hpf, and driving expression
in lens, diencephalon, and hindbrain subsequently (Fig-
ures 2D–2F and S2N–S2T). To assess whether disruption
of the putative PAX6 binding site (BS) would affect
enhancer activity, we tested two mutant versions of
SIMO in mouse and zebrafish transgenic assays: the exact
subject ID 1230P mutation (SIMO-T) and a multinucleo-
tide disruption of the putative PAX6 BS (SIMO(Pax6mut)).
Transgenic fish for both mutated versions (Figures 2G–2I)
lacked GFP signal in the lens but retained expression in
other parts of the embryos. In mouse transgenics,
compared with the wild-type element, LacZ expression in
both mutant versions was lost in the lens but remained
in hindbrain and diencephalon (Figures 2J–2O). Later-
stage expression in the retina is also lost in transgenic
mouse embryos with the mutant elements (Figure 2L).
We conclude that the mutation found in patient ID
1230P is sufficient to abolish activity of the SIMO
enhancer in developing ocular tissues.
We next investigated whether enhancer activity of SIMO
depends on the presence of Pax6. We first performed his-
tone H3 chromatin immunoprecipitations to ascertain
the active enhancer status of the endogenous SIMO frag-
ment in chromatin prepared from mouse E14.5 eyes.
qPCR revealed strong enrichment for monomethylated1128 The American Journal of Human Genetics 93, 1126–1134, DeceH3K4 (ab8895, Abcam) and acetylated H3K27 (ab4729,
Abcam) at the SIMO fragment compared to negative
(featureless intergenic fragments near mouse Wt1 and
Rcn1) control sequences from the locus (Figure 3A). ChIP
with Pax6 antibody (DSHB) revealed clear enrichment at
the SIMO element and the positive control fragment
(Pax6 P1 promoter) and a lack of enrichment at the nega-
tive controls (Figure 3B). A DNA affinity-capture assay via
biotinylated double-stranded oligonucleotides as probe
also efficiently pulled down Pax6 protein from a nuclear
extract of E14.5 eyes when the wild-type SIMO-G PAX6
binding sequence was used, but the efficiency of the
Pax6 pulldown was strongly reduced with the SIMO-T
mutant version of the probe (Figure 3C). This was
confirmed by an EMSA competition experiment where
the G>T change strongly reduced the ability to compete
for binding of purified PAX6 paired domain (Figure S3).
These results show that SIMO is an active enhancer in
E14.5 eyes and that Pax6 efficiently binds to a wild-type
SIMO-G but not a mutant SIMO-T fragment, albeit with
lower affinity than the optimal PAX6 consensus site.15
To determine how absence of Pax6 would affect func-
tional activity of the SIMO enhancer in vivo, we crossed
a SIMO-LacZ reporter allele onto the mouse mutant
smalleye (Pax6 null).18 smalleye homozygous embryos car-
rying the SIMO-LacZ transgene showed a distinct lack of
X-gal staining in the surface ectoderm and lens primor-
dium at E9.5 (Figure 3D) and E10.5 (Figure 3E), in compar-
ison with wild-type littermates, indicating that Pax6 is
required for activation of the SIMO element. SIMO-driven
reporter expression in the lens was also abolished in a
zebrafish mSIMO-GFP transgenic line upon coinjection
of morpholinos against zebrafish pax6.1a and pax6.1b.
Reporter activity was unaffected in fish injected with a
control morpholino (Figures 3F–3I). Immunoblotting of
morpholino-injected embryos confirmed effective deple-
tion of pax6 (Figure S3).
Having demonstrated the dependence of SIMO en-
hancer activity on Pax6 and its disruption by the subject’s
mutation, we wished to investigate whether SIMO-driven
enhancer activity is essential for the expression of PAX6.
In contrast to aniridia cases where chromosomal abnor-
malities had removed large collections of cis-regulatory
elements from the locus,4–6,13 no other small deletions or
regulatory mutations had been identified. This raised the
question of whether disruption of a single cis-element, in
the presence of multiple enhancers with overlapping tissue
specificity, could be sufficient to cause a disease pheno-
type. To determine the consequence of SIMO element
loss from its wider genomic context, we employed a BAC
transgenic approach. Because the size of the known
human PAX6 regulatory domain exceeds normal BAC
content, we used a BAC containing the more compact
X. tropicalis pax6 locus including all currently known lens
and retinal enhancers and inserted a GFP reporter into
the pax6 ATG start site by recombineering.19,20 Tol2 sites
flanking the insert were inserted into the BAC vector tomber 5, 2013
Figure 2. Characterization of SIMOWild-
Type and Mutant Enhancer Activity in
Zebrafish and Mouse Reporter Trans-
genics
Wild-type and mutant versions of the
SIMO element were cloned into appro-
priate transgenic reporter vectors by the
method described in Ravi et al.35 The
SIMO G>T mutation was PCR amplified
from the subject’s DNA, and the artificial
multinucleotide PAX6 BS mutation was
made with Quickchange site-directed
mutagenesis. Primers used are shown in
Table S4.
(A and B) Lateral views of transgenicmouse
embryos with the wild-type element show
expression in surface ectoderm at E9.5 (se)
and lens at E10.5 dpc and in hindbrain
(hb) and diencephalon (d).
(C) At later developmental stages, X-gal
staining is found in lens epithelium and
neuroretina.
(D–F) Comparable expression is seen in
stable transgenic zebrafish with mouse
SIMO element (mSIMO).
(D) At 24 hr postfertilization (hpf), no GFP
signal is yet detected.
(E) By 48 hpf, strong enhancer activity is
seen in the lens and more variably in dien-
cephalon and hindbrain.
(F) Expression is maintained at 72 hpf.
(G–I) Double fluorescent reporter trans-
genic zebrafish demonstrate the loss
of lens activity for the mutant SIMO
elements.
(G) Wild-type mouse SIMO linked to GFP
(mSIMO-GFP) in green and the multinu-
cleotide SIMO mutant linked to mCherry
(mSIMO(Pax6)-CHR) in red.
(H) Loss of enhancer activity in the eye by
the patient mutation is demonstrated in
comparative analysis of wild-type human
hSIMO-G-GFP versus the mutant hSIMO-
T-Cherry.
(I) The same result is seen when the re-
porters are swapped.
(J–R) Absence of eye expression in SIMO
mutant transgenic embryos.
(J and K) Two independent transgenic
embryos for the multinucleotide SIMO
mutant (mSIMO(Pax6)-Z) show absence
of lens expression.
(L) Staining is absent in SIMO mutant eyes
at E17.5.
(M) The human SIMO-G wild-type ele-
ment is expressed in lens, diencephalon,
and hindbrain.
(N and O) Sections through E17.5 hSIMO eyes show staining in lens epithelium, neuroretina, and ciliary margin (arrowhead) in
hSIMO-G (N) but not in hSIMO-T (O).
(P–R) Three independent transgenic embryos for hSIMO-T at E10.5 demonstrate loss of expression in the lens while di- and rhomben-
cephalon expression remains.allow Tol2-mediated transgenesis.21 The resulting wild-
type reporter BAC (BAC-XtPax6-GFP-Wt) was further
modified by deletion of the SIMO element (BAC-XtPax6-
GFP-DSIMO) (Figures 4A and S4). Zebrafish transgenic lines
were established for both BAC versions. The wild-type re-
porter BAC recapitulates the combined pax6 expression
patterns of the partially overlapping expression domainsThe American Jouof the two zebrafish pax6.1 genes (Figures 4B–4F).22,23
The same pattern is seen in transgenic fish for the SIMO-
deleted BAC at 24 hpf (Figures 4G and 4H). However, by
48 hpf, GFP expression is no longer detected in the lens
and remains conspicuously absent subsequently (Figures
4I–4K). Thus, deletion of the SIMO element from the wider
pax6 locus results in complete abolition of Pax6-GFPrnal of Human Genetics 93, 1126–1134, December 5, 2013 1129
Figure 3. Pax6 Binds to the SIMO Enhancer and Is Essential for Its Function
(A) Chromatin immunoprecipitation on chromatin, prepared from approximately 200 dissected mouse E14.5 embryonic eyes as
described,36 shows that the SIMO element is enriched for enhancer-associated histone modifications H3K4me1 (ab8895, Abcam) and
H3K27Ac (ab4729, Abcam; Table S3). The Pax6 P1 promoter is also positive for these marks, whereas featureless control fragments
located near the adjacent Wt1 and Rcn1 genes show minimal enrichment.
(B) ChIP with Pax6 antibody (DSHB) shows clear enrichment at the SIMO enhancer and Pax6 P1 promoter but not at the control regions.
qPCR primer sets used are shown in Table S4.
Relative enrichments are shown as mean percentage of input5 SEM (standard error of themean); *p< 0.05, **p< 0.01 (Student’s t test).
(C) Double-stranded DNA affinity capture assay from nuclear extract prepared from approximately 100 E14.5 mouse embryonic eyes via
NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Scientific, catalog number 78833), performed as described in Jeong
et al.28 Pax6 is efficiently pulled down with a probe representing the wild-type SIMO-G sequence (Table S4). Binding to the mutant
SIMO-T fragment is greatly reduced. Immunoblot via a mix of monoclonal anti-Pax6 antibodies (Table S3). Lane 1: precleared superna-
tant (Input); lane 2: beadwash fraction after extract binding; lane 3: final bead fraction via the wild-type SIMO-G probe; lane 4: final bead
fraction for the mutant SIMO-T probe; lane M: marker.
(D and E) Absence of functional Pax6 protein in vivo disrupts SIMO enhancer activity in the surface ectoderm and primordial lens of
homozygous smalleye (Sey) embryos at E9.5 (D) and E10.5 (E).
(F, H, and I [bottom embryo]) Injection of morpholinos (MO; Gene Tools) against zebrafish pax6.1a (50-AGTTCCAACAGCCTTTG
TATCCTCG-30) and pax6.1b (50-GCCTGAGCCCTTCCGAGCAAATCAG-30) in stable SIMO-GFP transgenic fish embryos results in loss
of reporter expression specifically in the lens, with variable phenotypic deformity of the embryos, notably a reduced eye size (arrows).
(G, H, and I [top embryo]) Injection with the Gene Tools standard negative control morpholino: 50-CCTCTTACCTCAGTTACAATTT
ATA-30 has no effect. White arrowhead indicates the eye.
Abbreviations are as follows: d, diencephalon; e, eye; hb, hindbrain; l, lens; nr, neuroretina.
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Figure 4. The SIMO Enhancer Is Essential for Expression of Pax6 in Its Wider Genomic Context
(A) Schematic representation of the modified BAC constructs containing the X. tropicalis Pax6 genomic locus, differing by the presence
(orange ellipse) or absence (open triangle) of the SIMO element. Modified BACs are based on X. tropicalis BAC CH216-109E08 (obtained
from CHORI BACPAC), transformed into the recombineering permissive bacterial strain SW102. A gfp3 reporter cassette was
inserted into the pax6 exon 4 translational start site by GalK positive/negative selection.19 Tol2 recombinase arms were then
placed in the BAC vector by the iTol2-ampicillin selection cassette.37 A 1.1 kb fragment covering the genomic coordinates from
scaffold_399:567,254–568,353 (JGI 4.1/xenTro2), containing the X. tropicalis conserved SIMO sequence, was removed from the SIMO
deleted BAC via rpsL/kanamycin selection recombineering.38 Primer sets used are shown in Table S4. The multitude of cis-elements pre-
sent in the Pax6 locus is represented by blue ellipses, including the lens-specific ectodermal enhancer10 (EE, orange).
(B–K) Temporal series of stable transgenic zebrafish carrying wild-type (B–F) or SIMO-deleted (G–K) reporter BAC transgenes. GFP signal
recapitulates the combined pax6 expression pattern, including forebrain (fb), hindbrain (hb), spinal cord (sc), neuroretina (nr), lens (l),
and pancreas (p).Wild-type and SIMO-deleted reporter patterns are identical at 24 hpf and lens expression is seen in both (B, C, G, H). By
48 hpf, GFP signal is absent from the lenses of SIMO-deleted BAC transgenic embryos, although being maintained in wild-type BAC
transgenics (D, I). GFP patterns remain similar in wild-type and SIMO-deleted BAC transgenic fish at 72 hpf and 5 days with the excep-
tion of lens expression (E, F, J, K).
(L) Model for the role of the autoregulatory PAX6 binding site in the SIMO enhancer, maintaining a positive feedback loop required for
PAX6 expression during eye development. Undefined enhancer(s) in the locus, possibly including EE, initiate PAX6 transcription in
early lens/surface ectoderm. Expression of PAX6 allows activation of the SIMO enhancer which, alone or in combination, maintains
expression of PAX6 at subsequent stages of eye development.expression in the lens after 24 hpf, despite the continued
presence of other defined lens enhancers on the BAC,
demonstrating that activity of the remote SIMO enhancerThe American Jouelement is critically required for continued tissue-specific
expression from the Pax6 promoters. Requirement of
PAX6 itself for the functional activity of the elementrnal of Human Genetics 93, 1126–1134, December 5, 2013 1131
suggested that the SIMO enhancer is not essential in the
initial activating phase of PAX6 gene expression but has
a role in maintenance of its transcription through a posi-
tive-feedback loop (Figure 4L). The finding that deletion
of SIMO from the BAC transgene has no apparent effect
on reporter expression in early embryos, but causes com-
plete loss of lens expression at subsequent stages, supports
this model. The model also highlights the notion that
equivalent effects on PAX6 lens expression can be pro-
duced by deletion of a remote regulatory element, absence
of a crucial trans-acting factor, or the mutation of a single
nucleotide in its binding site (Figure 4L).
We show that the SIMO enhancer is crucial for expres-
sion of PAX6 in developing ocular tissues. Disruption of
the PAX6 binding site within SIMO abolishes both lens
and late retinal expression in mouse transgenics, showing
that PAX6 binding is a critical event for both these func-
tions of the element. As a consequence it is presently
unclear whether the developmental defects leading to
the subject’s aniridia phenotype are due to misregulation
of PAX6 in the lens, retina, or both. Based on observations
from morula aggregation-derived Pax6þ/þ<>Pax6þ/ chi-
meric eyes in which the iris was not affected, even in
chimeras with a very high percentage of Pax6þ/ cells in
the iris, it was surmised that iris hypoplasia in aniridia
patients is a secondary effect of defective lens develop-
ment.24 However, heterozygous conditional inactivation
of Pax6 in either lens or retina separately showed no
obvious iris abnormality upon lens-specific inactivation
of one Pax6 allele, but iris hypoplasia was seen after hetero-
zygous Pax6 deletion in the retina.25 The latter observa-
tions suggest disruption of the retinal part of the SIMO
expression as the more likely causative event, but consid-
ering the intertwining of lens and retinal development,
further dissection of the SIMO element is needed to sepa-
rate the subdomains of SIMO-driven expression. It is likely
that activation of the SIMO enhancer in lens, retina, dien-
cephalon, and hindbrain depends on the presence (and
levels) of different combinations of common and unique
TFs in those tissues, binding to the appropriate subsets of
recognition sites within SIMO. Indeed, although the
Pax6 BS mutation affects lens and retinal expression, re-
porter activity in hindbrain and diencephalon appears
largely unaffected. Similarly, mutation of binding sites
for other TFs may selectively affect SIMO activity in a
different subset of tissues.
Genetic disease can be caused by mutation or deletion
of the transcribed part of a gene or by the disruption of
its appropriately regulated gene expression. A variety of
mechanisms interfering with proper expression control
and leading to congenital malformations have been
observed.5 In the large majority of such cases, a substantial
insult to the integrity of the cis-regulatory landscape
surrounding the disease-associated gene has occurred. At
present only a handful of cases involving single-nucleotide
changes in a remote regulatory element have been
described, representing a variety of subtly differing mech-1132 The American Journal of Human Genetics 93, 1126–1134, Deceanisms:26–30 creation of a cryptic promoter diverting
normal regulatory interaction in the a-globin locus in thal-
assemia (MIM 604131);26 multiple independent mutations
in the ZRS, a long-range enhancer for SHH, create an
ectopic gain-of-function effect in the limb bud causing
limb deformities;27 mutation of a BS for the transcriptional
activator SIX3 (MIM 603714) in the SHH SBE2 forebrain
enhancer leads to holoprosencephaly (MIM 142945),28
whereas a mutation in the BS for the YY1 repressor
(MIM 600013) leads to overexpression of HCFC1 (MIM
300019) in intellectual disability (MIM 309541);29 and a
mutation improving the binding affinity of a MSX1
(MIM 142983) BS in the remote HCNE-F2 enhancer
located 1.3 Mb upstream of SOX9 is implicated in Pierre
Robin Sequence (MIM 261800).30 The mutation in the
aniridia case described here adds a further mechanism to
this list: disruption of a positive feedback loop by the
mutation of an autoregulatory binding site. It further dem-
onstrates that even a single point mutation in a remote
enhancer located 150 kb from its target gene can have
severe consequences, highlighting the sensitivity of em-
bryonic development to disturbances at specific positions
in our genome. This stands in stark contrast to reports
that one can delete megabase segments of the genome31
or remove complete ultraconserved enhancers32 without
any apparent effect, which had suggested widespread
redundancy among enhancers for critical developmental
regulatory genes.33,34 These contrasting observations
underline the fact that our understanding of the cis-regula-
tory mechanisms governing the expression of our genome
is far from complete. Our work highlights the fact that,
despite the current bias toward mutation discovery in
exonic regions of the genome, detailed study of the role
of noncoding parts of the genome can make a valuable
contribution to our understanding of the mechanistic
variety of the causes of genetic disorders.Supplemental Data
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